Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

Trusted Partner Program Coming Soon - Update

Active
W911NF26RA009Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Trusted Partner Program (TPP), under solicitation W911NF-26-R-A009, is a quick-reaction contracting vehicle designed to facilitate rapid Research, Development, Technology, and Evaluation (RDT&E) between the U.S. Army, Joint Warfighter partners, and external academic or non-profit research institutions. The program focuses on sensitive projects across core technical fields including biology, material science, electronics, chemistry, information sciences, and physics, as well as interdisciplinary areas such as applied AI, quantum battlefield dominance, and hypersonics. The government intends to award one or more Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts with a base ordering period of five years and a potential five-year extension. Each awardee will have a total contract ceiling of 400 million dollars. The solicitation is currently on hold pending a review of Army priorities, which may lead to updates in the final Request for Proposals (RFP). Eligibility is restricted to institutes of higher education and non-profit research institutions, requiring CMMC Program Level 2 certification and the ability to handle various security classifications, ranging from Controlled Unclassified Information (CUI+) to Top Secret and Special Access Programs (SAP). Awards will be based on a best-value trade-off process, with technical capability being the most important factor, followed by management, past performance, small business participation, and cost. Proposals must include a specific technical expertise matrix and a video pitch demonstrating secure facilities. All invoicing and payments will be processed through the Wide Area WorkFlow (WAWF) system.

General Info

DoD seeks trusted academic partners for sensitive research supporting U.S. Army, deadline May 29, 2026.

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance

Durham, NC, USA

Set-Aside

NONE

Documents

(8)

DEVCOM ARO Trusted Partner Program Draft RFP Industry Day Presentation 07MAY2026

PDF•industry-day

Draft RFP for Trusted Partner Program W911NF-26-R-A009

PDF•rfp

Draft RFP for Trusted Partner Program W911NF-26-R-A009

PDF•rfp

FINAL Q&As Combined for Draft RFP Clarifications

DOCX•q-and-a

Implementation of Federal Investigative Standards Tiered Investigations

DOCX•other

Past Performance Questionnaire Template

DOCX•past-performance

TPP Matrix for Security Clearance and Expertise Levels

DOCX•other

Attachment+2+-+BLANK+DD254.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

6 updates
Posted

Presolicitation

Notice updated

The point of contact changed.

Notice updated

The point of contact changed.

Notice updated

The notice description changed.

Notice updated

Response deadline changed from May 29, 2026 to Jul 31, 2026. The notice title changed. The notice description changed.

Notice updated

Notice type changed from Presolicitation to Special Notice. The response deadline was removed. The notice title changed. The notice description changed. The point of contact changed.

Notice updated

The notice title changed. The notice description changed.

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → W6QK Acc-Apg Durham
Contacts2 people available
OfficeRESEARCH TRIANGLE PAR, NC, 27709-2211, USA
Office AddressRESEARCH TRIANGLE PAR, NC, 27709-2211, USA
Contacts
Ann Thompson Contracting Officer ACC (APG) RTP

Full Description

Show more

Notice of Upcoming solicitation Release - Update


The release of Solicitation W911NF-26-R-A009 is on hold pending an ongoing review of Army priorities, which may result in updates to the RFP. Interested parties are encouraged to monitor www.sam.gov for the official announcement and subsequent updates.




Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Federal
ARPA-H Comprehensive Organ System Modeling in Outer Space (COSMOS) Innovative Solutions Opening
Solicitation # ARPA-H-SOL-26-165
The Advanced Research Projects Agency for Health (ARPA-H) is seeking proposals under solicitation ARPA-H-SOL-26-165 for the Comprehensive Organ System Modeling in Outer Space (COSMOS) initiative. This program aims to determine if microgravity in Low Earth Orbit (LEO) accelerates tissue aging across brain, cardiac, uterine, and kidney tissues compared to terrestrial rates. If the Tissue Aging Rate in Space (TARIS) is found to significantly exceed the Tissue Aging Rate on Earth (TAROE), the initiative intends to establish a high-throughput, autonomous drug screening platform in LEO to make biomedical research and development more cost-effective and faster than Earth-based methods. The project is structured into two sequential phases: a 27-month Phase I focused on establishing and validating microphysiological systems (MPS) to quantify aging rates, and a 15-month Phase II dedicated to developing age-related pathology models for pro-regenerative drug testing. Key requirements include the use of MPS or organoids for at least 75 percent of experimental samples, the creation of LEO twin experiments, and the establishment of a contractual partnership with at least one Fortune 100 biopharmaceutical company. The program schedule spans FY27 through FY30 and includes two planned space launches in months 39 and 41. Awards will be granted via multiple Other Transaction (OT) Agreements to the most advantageous proposers, including universities, non-profits, and businesses. Evaluation is based primarily on the innovation and feasibility of the technical approach, the potential to transform biomedicine, and the team's expertise in managing costs and schedules. Proposers must adhere to strict administrative requirements, including the BIOSECURE Act, NIH Genomic Data Sharing policies, and specific research security and cybersecurity disclosures. Full proposals are due by October 7, 2026.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

5 days ago

DEADLINE

in 8 days
View Details
NAICS: 541714
New
Federal
ARPA-H Emerging Health Innovators (EHI) Initiative
Solicitation # ARPA-H-SOL-26-150
The Advanced Research Projects Agency for Health (ARPA-H) Emerging Health Innovators (EHI) initiative, solicitation ARPA-H-SOL-26-150, is a mentorship program designed to identify and engage early-career investigators for cutting-edge biomedical, health, and community-engaged research. Eligible principal investigators must be within eight years of completing their first terminal degree. The program focuses on 16 specific topic areas and utilizes a two-step submission process, beginning with an anonymized solution summary due October 30, 2026, followed by full proposals due February 10, 2027. Awards are issued as Other Transaction (OT) agreements with a tentative start date of June 30, 2027. Each award has a total value not to exceed 1,050,000 dollars over a three-year period, consisting of a two-year base period capped at 700,000 dollars and an optional third year capped at 350,000 dollars. Funding is structured around a fixed-price milestone payment schedule, with 12 total quarterly milestones and payments processed through the Payment Management Services (PMS) system. Performance is monitored via monthly one-hour virtual reviews with the ARPA-H program team. Evaluation is based on technical merit, innovativeness, feasibility, and alignment with the ARPA-H mission, with a strong emphasis on risk mitigation and the potential to impact national health research.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

5 days ago

DEADLINE

in 4 months
View Details
NAICS: 541714
New
Grant
NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
Solicitation # PAR-28-072
The National Institutes of Health National Eye Institute is offering a bi-phasic, milestone-driven award through the Translational Research Program for Therapeutics (PAR-28-072) to accelerate the transition of laboratory research into biological, pharmaceutical, or medical device therapies for visual system diseases. The program is structured into two phases: an R61 phase of up to two years focusing on preliminary data and lead optimization, and an R33 phase of up to four years dedicated to final preclinical development and the filing of an Investigational New Drug or Investigational Device Exemption application with the FDA. The total combined duration of both phases cannot exceed five years. Transition to the R33 phase is contingent upon the administrative assessment of satisfactory completion of SMART milestones, which must include required pre-submission feedback from the FDA. Budgetary limits for direct costs are generally capped at 500,000 dollars per year for the R61 phase and 1,000,000 dollars per year for the R33 phase. Applicants must provide a Target Product Profile, a Gantt chart, and an Intellectual Property Strategy, while ensuring compliance with Good Manufacturing Practices and Good Laboratory Practice standards. Evaluation is based on the importance of the research, rigor and feasibility of the approach, and the expertise of the investigators and their environment. Eligible applicants, including small businesses and other for-profit organizations, must maintain active registrations in the System for Award Management and eRA Commons, and all principal investigators must have a linked ORCID ID. Awardees are also required to implement cybersecurity incident reporting procedures and an incident response plan in accordance with HHS guidelines.
National Institutes Of Health

POSTED

5 days ago

DEADLINE

in about 3 years
View Details
NAICS: 541714
New
Grant
Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)
Solicitation # PAR-28-056
The National Institutes of Health, through the National Cancer Institute, is soliciting applications for Research Units (RUs) to join the Pancreatic Cancer Detection Consortium (PCDC). This initiative focuses on the early detection of pancreatic ductal adenocarcinoma (PDAC) and the characterization of precursor lesions to identify high-risk patients. Multi-disciplinary teams will conduct research to identify and test molecular and imaging biomarkers in bodily fluids, develop markers for pancreatic cysts, create screening approaches for high-risk populations, and utilize machine learning for biomarker discovery and validation. Additionally, RUs are required to collect longitudinal biospecimens for a biorepository and engage in collaborative data and resource sharing within the consortium. The award has a five-year project period with a budget limit of 600,000 dollars in direct costs per year. For years two through five, recipients must set aside 100,000 dollars in direct costs annually for trans-PCDC collaborative studies, subject to Steering Committee approval. Key personnel requirements include a minimum commitment of 1.2 person-months per year for the Contact PD/PI and any other PD/PIs. Eligible applicants include for-profit organizations and small businesses, though foreign entities are excluded. Applications are evaluated via the NIH peer review system based on significance, innovation, feasibility, and the expertise of the investigators and their environment. Compliance requirements include maintaining active SAM and eRA Commons registrations and adhering to strict cybersecurity incident reporting timelines of 48 hours. Projects involving clinical trials must be registered on ClinicalTrials.gov and receive NIH approval prior to initiation. Required application materials include SF424 forms, a Resource Sharing Plan, a Data Management and Sharing Plan, and letters of institutional commitment. Awardees must also budget for travel to attend two Steering Committee meetings annually.
National Institutes Of Health

POSTED

5 days ago

DEADLINE

in about 3 years
View Details
NAICS: 541714
New
Federal
UNifying Imaging with QUantum Entanglement (UNIQUE) Innovative Solutions Opening (ISO)
Solicitation # ARPA-H-SOL-26-162
The Advanced Research Projects Agency for Health (ARPA-H) has issued Innovative Solutions Opening (ISO) ARPA-H-SOL-26-162 for the UNifying Imaging with QUantum Entanglement (UNIQUE) program. This 18-month, two-phase initiative seeks to develop a new biomedical imaging paradigm by integrating anatomical, functional, and molecular data with quantum-derived observables and entangled 511 keV photon pairs. The scope is divided into two technical areas: TA1, which focuses on the physical systems required to generate and measure quantum observables in biomedical settings, and TA2, which focuses on the computational foundation, including AI-driven reconstruction and multimodal data fusion. ARPA-H anticipates awarding multiple Other Transaction (OT) Agreements to eligible entities, including universities, non-profit organizations, and businesses. For-profit organizations that exceed the NAICS 541714 SBA size standard of 1,000 employees are required to provide a meaningful cost share. The application process follows a two-stage submission cycle, with Solution Summaries due by late October 2026 and Full Proposals due by December 15, 2026, with a final response deadline of December 16, 2026. Full proposals must consist of three volumes covering technical and management plans, cost proposals, and administrative requirements. Evaluation is based on the innovation and feasibility of the technical approach, the expertise of the personnel, the potential to transform biomedicine, and cost reasonableness. Key requirements include compliance with HHS regulations on human stem cells, adherence to cybersecurity standards, and restrictions on gain-of-function research and funding for foreign entities in countries of concern. Awardees will be expected to provide monthly status reports and participate in semi-annual in-person PI review meetings.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

6 days ago

DEADLINE

in 3 months
View Details
NAICS: 541714
New
Federal
HUBBLE DRAFT Program Announcement (PA)
Solicitation # DARPA-PA-26-10_DRAFT
The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office is issuing a presolicitation notice for the HUBBLE program, which aims to develop an in-silico capability for mapping all protein-protein interactions. The goal is to create a comprehensive human interactome hypercatalog, demonstrating its utility by identifying novel diagnostic and therapeutic targets for conditions such as traumatic brain injury. The program is structured in two phases, with Phase 1 lasting 12 months and Phase 2 lasting 18 months. Key deliverables include the development of PPI fingerprinting capabilities, the capture of a minimal interactome for mild traumatic brain injury, and the generation of a massive PPI hypercatalog benchmarked against DARPA-provided experimental datasets. Awards will be issued as Other Transactions for Research under 10 U.S.C. 4021, meaning they are not subject to the Federal Acquisition Regulation or the Defense Federal Acquisition Regulations Supplement. Eligible applicants include large and small businesses, universities, research institutions, and nontraditional defense contractors. Proposers must be registered in the System for Award Management and maintain CMMC Level 1 compliance. Evaluation is based on technical comprehension, technical ability, and the reasonableness of the cost rough order of magnitude. Submissions must be made via DARPA's Broad Agency Announcement Tool, and all abstracts must remain unclassified.
Defense Advanced Research Projects Agcy

POSTED

6 days ago

DEADLINE

in 3 days
View Details
NAICS: 541714
New
Federal
UNifying Imaging with QUantum Entanglement (UNIQUE) Proposers' Day
Solicitation # ARPA-H-SN-26-162
The Advanced Research Projects Agency for Health (ARPA-H), through its Health Science Futures Office, has issued Special Notice ARPA-H-SN-26-162 to announce the UNifying Imaging with QUantum Entanglement (UNIQUE) program. This initiative aims to establish a new biomedical imaging paradigm by utilizing quantum-derived observables, specifically entangled or quantum-correlated 511 keV photon pairs, to reveal disease biology that is currently invisible to existing imaging technologies. The program is divided into two technical areas: an Imaging Core focused on physical systems and quantum-aware detectors, and a second area focused on AI-driven reconstruction and fusion methods to integrate anatomical, functional, molecular, and quantum-derived information. To support this effort, a hybrid Proposers Day is scheduled for October 16, 2026, at 8:30am ET, held at the Executive Conference Center in Arlington, Virginia. This event is designed to provide technical details, promote teaming, and alert the scientific community to an upcoming Innovative Solutions Opening (ISO) that was scheduled for release by September 18, 2026. Interested parties are encouraged to use the provided Lightning Talk Template to showcase their capabilities and teaming goals. While this notice provides program goals and technical direction, it is issued for information and planning purposes and does not constitute a formal solicitation for proposals. The primary point of contact for the program is Program Manager Wilfred Ngwa.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

6 days ago

DEADLINE

in 15 days
View Details

More opportunities from Department Of Defense → W6QK Acc-Apg Durham

Same awarding agency

NAICS: 541715
New
Federal
SOURCES SOUGHT FOR COOPERATIVE RESEARCH & DEVELOPMENT PARTNERSHIPS HYPERSONIC INFRARED TARGET SENSING – TRANSITION OPPORTUNITY (HITS-TO)
Solicitation # W911NF-26-HITS-TO
Solicitation W911NF-26-HITS-TO is a Sources Sought notice issued by the Department of Defense, specifically the W6QK Acc-Apg Durham office, to establish Cooperative Research & Development Partnerships (CRADAs). The initiative, titled Hypersonic Infrared Target Sensing – Transition Opportunity (HITS-TO), seeks U.S. partners from industry, national laboratories, University Affiliated Research Centers (UARCs), and Federally Funded Research and Development Centers (FFRDCs) to collaborate with Department of Defense laboratories. The primary goal is to mature transformational innovations and leap-ahead technologies to integrate infrared seekers onto hypersonic weapons, specifically targeting a Technology Readiness Level (TRL) of 6 or higher. Key technical objectives include developing advanced imaging and tracking systems capable of operating through hypersonic turbulence and platform vibrations, as well as maturing IR-transparent materials and coatings that can survive extreme hypersonic flight conditions. This is a market research effort and no funding is provided through this notice; preference is given to partners capable of self-funding their portion of the collaboration for up to five years. Interested respondents must submit a Technical Capability Summary Statement (TCSS) not exceeding six pages, along with a detailed cover sheet including their Unique Entity ID and CAGE code. Due to the sensitive nature of the technology, partners must demonstrate the ability to handle Controlled Unclassified Information (CUI) in accordance with NIST SP 800-171 and provide a current DD2345. Requirements also include stating the entity's Facility Clearance level and confirming that Principal Investigators hold the necessary Personnel Clearances for classified discussions. Submissions are due by September 30, 2026, via email or the DoD SAFE portal.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 12 hours ago

DEADLINE

in 16 days
View Details
NAICS: 541715
Federal
DevX Autonomy
Solicitation # W911NF26S0040
The DevX Autonomy initiative, managed by the Transformation and Training Command and the Army Applications Laboratory, is a long-term open call solicitation under solicitation number W911NF26S0040. The program seeks innovative Autonomous Unmanned System solutions across air, ground, and maritime platforms, including payloads, mission-enabling tools, lethal capabilities, and sustainment subcomponents. The goal is to identify hardware and software solutions that close capability gaps and advance the state of the art in autonomy, utilizing a modular open systems approach. Eligible U.S. and foreign entities must submit an unclassified video pitch of six minutes or less and a completed submission form via the designated online portal. Submissions are evaluated by government subject matter experts based on technical merit, technical approach, alignment, company qualifications, and the ability to define the problem. Solutions deemed award-ready may be transitioned through various rapid acquisition pathways, including fixed-price licenses or services. The solicitation is continuously open from December 30, 2025, through July 31, 2026, with monthly collection cycles and results typically provided within 30 days of the period's end. All submissions must be unclassified and free of restrictive markings, except for valid copyright notices, to be eligible for assessment.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 1 month ago

DEADLINE

in about 1 month
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS